| Name | Epidermal Growth Factor |
|---|---|
| Synonyms |
REC IDERMAL OWTH FACTOR (HUMAN)
IDERMAL OWTH FACTOR, MOUSE ADE I) MURINE URG IDERMAL OWTH FACTOR (EGF) HUMAN Tumor-associated calcium signal transducer 1 EGF, HUMAN a-iderMal owth factor (huMan) MEGF ADE I) IDERMAL OWTH FACTOR HUMAN, RECOMBINA NT EXPRESSED IN E. COLI MURINE EGF *recombinant expres MURINE IDERMAL OWTH FACTOR IDERMAL OWTH FACTOR, MURINE rh-EGF IDERMAL OWTH FACTOR HUMAN UROGASTRONE sh-Oligoptide-1/rh-Oligoptide-1 (Human EGF) NMEGF ASN-SER-ASP-SER-GLU-CYS-PRO-LEU-SER-HIS-ASP-GLY-TYR-CYS-LEU-HIS-ASP-GLY-VAL-CYS-MET-TYR-ILE-GLU-ALA-LEU-ASP-LYS-TYR-ALA-CYS-ASN-CYS-VAL-VAL-GLY-TYR-ILE-GLY-GLU-G-CYS-GLN-TYR-G-ASP-LEU-LYS-TRP-TRP-GLU-LEU-G sH-Oligoptide-1, Nidermin idermal owth Factor human,EGF IDERMAL OWTH FACTOR, MOUSE rhEGF, Human Oligoptide-1 EGF, MURINE SUBMAXILLY GLAND LONG EGF longtm egf human IDERMAL OWTH FACTOR, HUMAN, RECOMBINANT idermal owth Factor, human, animal component free latrophilin and seven transmembrane domain-containing protein 1 Major gastrointestinal tumor-associated protein GA733-2 IDERMAL OWTH FACTOR, MURINE SUBMAXILLY GLANDS HUMAN URG REC IDERMAL OWTH FACTOR HUMAN IDERMAL OWTH FACTOR EGF, MURINE ithelial cell surface antigen EGF, MOUSE IDERMAL OWTH FACTOR, MURINE SUBMAXILLY GLAND RECOMBINANT MOUSE EGF RECOMBINANT HUMAN EGF RHEGF MOUSE EGF EGF,sh-oligoptide-1,rh-EGF EGF Antigen EGF-TM7-latrophilin-related protein HUMAN EGF Human Oligoptide-1 MFCD00132565 Recombinant human idermal owth factor (rhEGF) injectable ade HOMG4 REC EGF (HUMAN) IDERMAL OWTH FACTOR, HUMAN ithelial glycoprotein MURINE UROGASTRONE nepidermin Recombinant human idermalowth factor (rhEGF) Anti-TACD1 antibody produced in rabbit EINECS 263-468-7 URG, HOMG4 |
| Description | Epidermal growth factor (EGF) is the key regulatory factor in promoting cell survival. Epidermal growth factor (EGF) signaling pathways are related with apoptosis. Loss of Epidermal growth factor (EGF) leads to embryonic or perinatal lethality with abnormalities in multiple organs. Epidermal growth factor (EGF) can stimulate reactive oxygen species (ROS) production for a short period of time in cells. Epidermal growth factor (EGF) can be used to research development and cancer[1][2]. |
|---|---|
| Related Catalog | |
| Target |
Apoptosis, ROS[1][2] |
| In Vitro | Epidermal growth factor (EGF) (500 ng/mL; 0-20 min) can induce the production of ROS in A431 cells[1]. Epidermal growth factor (EGF)-induced tyrosine phosphorylation of various cellular proteins was completely blocked in A431 cells containing exogenous catalase[1]. |
| In Vivo | Epidermal growth factor (EGF) (Osmotic pump delivered over 8 days at 10 pg/day) exhibits a highly significant stimulatory effect on wound closure in male mice[3]. Animal Model: C57BL6J and CBA mice (0.5-cm2 full-thickness back wound was cut out of the center of the back)[3] Dosage: 10 μg/day Administration: Osmotic pump delivered over 8 days at 10 pg/day Result: Exhibited a highly significant (P < 0.001) stimulatory effect on wound closure over 6 days in male mice. |
| Molecular Formula | C270H401N73O83S7 |
|---|---|
| Molecular Weight | 6221.96723999994 |
| Appearance | powder |
| Storage condition | 2-8°C |
| Personal Protective Equipment | Eyeshields;Gloves;type N95 (US);type P1 (EN143) respirator filter |
|---|---|
| RIDADR | NONH for all modes of transport |
| WGK Germany | 3 |
| RTECS | KB4518000 |